165 related articles for article (PubMed ID: 15920021)
81. Therapeutic approach to target mesothelioma cancer cells using the Wnt antagonist, secreted frizzled-related protein 4: Metabolic state of cancer cells.
Perumal V; Pohl S; Keane KN; Arfuso F; Newsholme P; Fox S; Dharmarajan A
Exp Cell Res; 2016 Feb; 341(2):218-24. PubMed ID: 26868304
[TBL] [Abstract][Full Text] [Related]
82. Dictyostelium development: a prototypic Wnt pathway?
Harwood AJ
Methods Mol Biol; 2008; 469():21-32. PubMed ID: 19109699
[TBL] [Abstract][Full Text] [Related]
83. Expression pattern of mouse sFRP-1 and mWnt-8 gene during heart morphogenesis.
Jaspard B; Couffinhal T; Dufourcq P; Moreau C; Duplàa C
Mech Dev; 2000 Feb; 90(2):263-7. PubMed ID: 10640709
[TBL] [Abstract][Full Text] [Related]
84. Secreted frizzled-related protein-1 improves postinfarction scar formation through a modulation of inflammatory response.
Barandon L; Casassus F; Leroux L; Moreau C; Allières C; Lamazière JM; Dufourcq P; Couffinhal T; Duplàa C
Arterioscler Thromb Vasc Biol; 2011 Nov; 31(11):e80-7. PubMed ID: 21836067
[TBL] [Abstract][Full Text] [Related]
85. Winding through the WNT pathway during cellular development and demise.
Li F; Chong ZZ; Maiese K
Histol Histopathol; 2006 Jan; 21(1):103-24. PubMed ID: 16267791
[TBL] [Abstract][Full Text] [Related]
86. SFRP-4 abrogates Wnt-3a-induced beta-catenin and Akt/PKB signalling and reverses a Wnt-3a-imposed inhibition of in vitro mammary differentiation.
Constantinou T; Baumann F; Lacher MD; Saurer S; Friis R; Dharmarajan A
J Mol Signal; 2008 May; 3():10. PubMed ID: 18452624
[TBL] [Abstract][Full Text] [Related]
87. Secreted frizzled related protein 4 reduces fibrosis scar size and ameliorates cardiac function after ischemic injury.
Matsushima K; Suyama T; Takenaka C; Nishishita N; Ikeda K; Ikada Y; Sawa Y; Jakt LM; Mori H; Kawamata S
Tissue Eng Part A; 2010 Nov; 16(11):3329-41. PubMed ID: 20528676
[TBL] [Abstract][Full Text] [Related]
88. Epm2a suppresses tumor growth in an immunocompromised host by inhibiting Wnt signaling.
Wang Y; Liu Y; Wu C; Zhang H; Zheng X; Zheng Z; Geiger TL; Nuovo GJ; Liu Y; Zheng P
Cancer Cell; 2006 Sep; 10(3):179-90. PubMed ID: 16959610
[TBL] [Abstract][Full Text] [Related]
89. Frizzled A, a novel angiogenic factor: promises for cardiac repair.
Barandon L; Couffinhal T; Dufourcq P; Ezan J; Costet P; Daret D; Deville C; Duplàa C
Eur J Cardiothorac Surg; 2004 Jan; 25(1):76-83. PubMed ID: 14690736
[TBL] [Abstract][Full Text] [Related]
90. Patterning skin pigmentation via dickkopf.
Chang HY
J Invest Dermatol; 2007 May; 127(5):994-5. PubMed ID: 17435783
[TBL] [Abstract][Full Text] [Related]
91. Protein kinases and kinase-modulated effectors in the late phase of ischemic preconditioning.
Baines CP; Pass JM; Ping P
Basic Res Cardiol; 2001; 96(3):207-18. PubMed ID: 11403414
[TBL] [Abstract][Full Text] [Related]
92. Secreted frizzled related protein 2 (Sfrp2) is the key Akt-mesenchymal stem cell-released paracrine factor mediating myocardial survival and repair.
Mirotsou M; Zhang Z; Deb A; Zhang L; Gnecchi M; Noiseux N; Mu H; Pachori A; Dzau V
Proc Natl Acad Sci U S A; 2007 Jan; 104(5):1643-8. PubMed ID: 17251350
[TBL] [Abstract][Full Text] [Related]
93. [Molecular mechanisms regulating neuronal polarity via phosphorylation signaling].
Yoshimura T; Arimura N; Hattori A; Kaibuchi K
Tanpakushitsu Kakusan Koso; 2007 Jun; 52(7):753-9. PubMed ID: 17552280
[No Abstract] [Full Text] [Related]
94. Ischemia-reperfusion injury: molecular mechanisms and therapeutic targets.
Zhang M; Liu Q; Meng H; Duan H; Liu X; Wu J; Gao F; Wang S; Tan R; Yuan J
Signal Transduct Target Ther; 2024 Jan; 9(1):12. PubMed ID: 38185705
[TBL] [Abstract][Full Text] [Related]
95. The secretome as a biomarker and functional agent in heart failure.
Nyarko OO; Sucharov CC
J Cardiovasc Aging; 2023 Jul; 3(3):. PubMed ID: 37484982
[TBL] [Abstract][Full Text] [Related]
96. Modeling incomplete penetrance in arrhythmogenic cardiomyopathy by human induced pluripotent stem cell derived cardiomyocytes.
De Bortoli M; Meraviglia V; Mackova K; Frommelt LS; König E; Rainer J; Volani C; Benzoni P; Schlittler M; Cattelan G; Motta BM; Volpato C; Rauhe W; Barbuti A; Zacchigna S; Pramstaller PP; Rossini A
Comput Struct Biotechnol J; 2023; 21():1759-1773. PubMed ID: 36915380
[TBL] [Abstract][Full Text] [Related]
97. ROS-Influenced Regulatory Cross-Talk With Wnt Signaling Pathway During Perinatal Development.
Chatterjee S; Sil PC
Front Mol Biosci; 2022; 9():889719. PubMed ID: 35517861
[TBL] [Abstract][Full Text] [Related]
98. Lcz696 Alleviates Myocardial Fibrosis After Myocardial Infarction Through the sFRP-1/Wnt/β-Catenin Signaling Pathway.
Liu J; Zheng X; Zhang C; Zhang C; Bu P
Front Pharmacol; 2021; 12():724147. PubMed ID: 34539406
[No Abstract] [Full Text] [Related]
99. Secreted Frizzled Related Proteins in Cardiovascular and Metabolic Diseases.
Guan H; Zhang J; Luan J; Xu H; Huang Z; Yu Q; Gou X; Xu L
Front Endocrinol (Lausanne); 2021; 12():712217. PubMed ID: 34489867
[TBL] [Abstract][Full Text] [Related]
100. Yap Promotes Noncanonical Wnt Signals From Cardiomyocytes for Heart Regeneration.
Liu S; Tang L; Zhao X; Nguyen B; Heallen TR; Li M; Wang J; Wang J; Martin JF
Circ Res; 2021 Oct; 129(8):782-797. PubMed ID: 34424032
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
